Related Articles
Novel AXL‑targeted agents overcome FLT3 inhibitor resistance in FLT3‑ITD+ acute myeloid leukemia cells
Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression
Internal tandem duplication and tyrosine kinase domain mutations in FLT3 alter the response to daunorubicin in Ba/F3 cells
Role of glucose metabolism in the differential antileukemic effect of melatonin on wild‑type and FLT3‑ITD mutant cells
Discovery of LDD‑1075 as a potent FLT3 inhibitor